Summit Therapeutics (SMMT) EPS (Diluted) (QoQ) (2017 - 2024)
Summit Therapeutics (SMMT) EPS (Diluted) (QoQ) (2017 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Summit Therapeutics | 11.62 Bn | 11.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -21.22% |
| Sep 30, 2024 | 5.51% |
| Jun 30, 2024 | -36.62% |
| Mar 31, 2024 | -2.64% |
| Dec 31, 2023 | -88.32% |
| Sep 30, 2023 | -21.39% |
| Jun 30, 2023 | 98.08% |
| Mar 31, 2023 | -1,271.41% |
| Dec 31, 2022 | 11.52% |
| Sep 30, 2022 | 11.38% |
| Jun 30, 2022 | 41.51% |
| Mar 31, 2022 | 22.06% |
| Dec 31, 2021 | -46.08% |
| Sep 30, 2021 | 25.33% |
| Jun 30, 2021 | -27.55% |
| Mar 31, 2021 | -8.42% |
| Dec 31, 2020 | 26.20% |
| Sep 30, 2020 | -16.13% |
| Jun 30, 2020 | -141.38% |
| Mar 31, 2020 | 93.40% |